Characteristics of Patients with Prominent Bone Marrow Uptake
| Characteristic | Patient 1* | Patient 2† | Patient 3‡ | Patient 4§ |
|---|---|---|---|---|
| Marrow involvement | Yes, % not reported | NR | 20% | No |
| Spleen visualized | Yes, intense | Yes, intense | No | No |
| Tumor visualized | Yes | Yes | No | No |
| Blood pool visualized | No on 24-h image | No | Yes on 3-h image | No on 24-h image |
| Human antimouse antibody | Negative | NR | NR | Negative |
| Cytotoxic chemotherapy | Ifosfamide, etoposide, carboplatin 10 wk earlier | NR | Fludarabine 8 mo earlier | Cisplatin, cytarabine 3 mo earlier |
| Granulocyte colony-stimulating factor use | 10 wk earlier | NR | NR | No |
| Interleukin use | 9 wk earlier | NR | NR | No |
| Erythropoietin use | No | Yes, up to time of scan | NR | No |